ATA Satellite Symposium

2014 American Thyroid Association (ATA) Guidelines on
Thyroid Nodules and Differentiated Thyroid Cancer –
Highlights, Consensus, and Controversies
Friday, June 20, 2014, 12:30 PM-5:20 PM
McCormick Place
West, Chicago, Illinois

A webcast and enduring CME for the June 20, 2014 ATA program is available for purchase.

 June 20, 2014 live course participants who still need to claim CME , please email education@endocrine.org to complete the meeting evaluation and receive your CME certificate.

 The ATA Guidelines for the Management of Thyroid Nodules and Differentiated Thyroid Cancer are still in development. A specific release/publication date is not available at this time. Please revisit the ATA website at www.thyroid.org for updates as available.

All current ATA Guidelines and Statements can be found on the ATA Guidelines page at: http://www.thyroid.org/thyroid-guidelines/

Program Description: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer (DTC) is becoming increasingly prevalent. A large amount of new information and evidence grading processes has become available since the 2009 guidelines. This has prompted the American Thyroid Association (ATA) to develop new and updated evidence-based recommendations to assist in the clinical management of patients with thyroid nodules and DTC. Authors from the international community of thyroid specialists in endocrinology and surgery will discuss recently published guidelines with special focus on:

  • Case based applications of the revised guidelines;
  • New guidelines in 2014; and
  • Contemporary optimal care for patients with thyroid nodules and differentiated thyroid cancer.
Agenda:
12:30 PM – 12:35 PM
 Welcome and Introductions
Bryan R. Haugen, MD, University of Colorado School of Medicine
   
12:35 PM – 12:45 PM   Process of Development and Format of the 2014 Nodules/DTC Guidelines
Bryan R. Haugen, MD
   
    Approaches to Patients with Thyroid Nodules  
12:45 PM – 1:00 PM    

Use of Neck Ultrasound to Guide Fine Needle Aspiration Decision-Making

    Susan J. Mandel, MD, University of Pennsylvania
1:00 PM – 1:15 PM Cytologic and Surgical Pathology Considerations
    Yuri Nikiforov, MD, PhD, University of Pittsburgh Medical Center
1:15 PM – 1:30 PM Use of Molecular Markers to Guide Decision-Making
    David L. Steward, MD, University of Cincinnati
1:30 PM – 1:50 PM Questions and Answers
   
  Approaches to Initial Therapy for Differentiated Thyroid Cancer
1:50 PM – 2:05 PM  Preoperative Disease Mapping and Voice Assessment
    Gregory W. Randolph, MD, Massachusetts Eye and Ear Infirmary
2:05 PM – 2:20 PM   Surgical Approach and Considerations
    Julie Ann Sosa, MD, Duke University School of Medicine
2:20 PM – 2:35 PM Staging and Risk Stratification Updates
     Erik K. Alexander, MD, Brigham & Women’s Hospital
2:35 PM – 2:50 PM    Updates on Radioactive Iodine Use – Consideration, Dosing, Preparation
    Anna M. Sawka, MD, Toronto General Hospital
2:50 PM – 3:05 PM  Integrating Response to Therapy in Monitoring Management
    R. Michael Tuttle, MD, Memorial Sloan-Kettering Cancer Center
3:05 PM – 3:25 PM   Questions and Answers
   
3:25 PM – 3:45 PM          BREAK
   
  Approaches to Patients with Advanced DTC
3:45 PM – 4:00 PM  Monitoring and Directed Therapy for Radioactive Iodine-Refractory DTC
      Furio Pacini, MD, University of Siena
4:00 PM – 4:15 PM  Systemic Therapy and Clinical Trials for Radioactive Iodine-Refractory DTC
    Keith C. Bible, MD., PhD, Mayo Clinic
4:15 PM – 4:30 PM    Questions and Answers
     
4:30 PM – 5:20 PM   Case-Based Discussion on Practical Applications of the 2014 Nodules/DTC Guidelines
  Bryan R. Haugen, MD/Panel (comprised of speakers noted above)          
   

Agenda for printing and Saving (PDF file, 139.79 KB)


84th Annual Meeting registration opening in April 2014; visit www.thyroid.org for updates as available